Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan;53(2):854-864.
doi: 10.1007/s00259-025-07476-9. Epub 2025 Jul 23.

Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation

Affiliations

Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation

Nabeel Mansour et al. Eur J Nucl Med Mol Imaging. 2026 Jan.

Abstract

Purpose: Somatostatin receptor (SSTR)-targeted PET/CT provides valuable clinical insights beyond standard imaging in meningioma patients. Due to its excellent diagnostic capabilities and favorable logistics, the 18F-labeled SSTR-targeting peptide SiTATE is increasingly in demand. We aimed to validate a recently proposed standard uptake value (SUV) threshold for accurate meningioma delineation in a clinically diverse patient cohort, including complex anatomical locations and lesions with prior surgical intervention.

Methods: Consecutive patients with known or suspected meningioma who underwent [18F]SiTATE PET/CT and contrast enhanced cerebral MRI were included. Lesions were semi-automatically segmented on PET images using an individualized minimal SUV (SUVmin) within a manually defined volume of interest. Correlative CT and MRI images were used to refine segmentations for each lesion, identifying the optimal lesion-specific SUVmin to accurately capture the true volume of the meningioma. All lesions were additionally segmented using the recently proposed threshold of 4.0, and resulting volumes were compared.

Results: 61 patients with 109 lesions were analyzed: 40 (37%) extraosseous, 32 (29%) partial trans-osseous, and 37 (34%) predominantly intraosseous. The median optimal SUVmin for lesion delineation was 4.2. Osseous involvement did not significantly affect the median SUVmin (p = 0.1). Individualized SUV volumes showed excellent absolute agreement with those obtained using the fixed threshold of 4.0 (ICC[A,1] = 0.967; 95% CI: 0.952-0.977; p < 0.0001). However, 17 lesions (SUVmax < 4.2) were not captured by the fixed threshold.

Conclusion: The proposed SUV threshold of 4.0 showed promising results, supporting its suitability for clinical practice. Although limitations were evident, with 16% of lesions - primarily very small - showing reduced uptake and therefore not captured by this threshold, the study underscores its applicability in clinical practice.

Keywords: Meningioma; PET/CT; Segmentation; SiTATE; Threshold.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval: This study complied with the Declaration of Helsinki and its amendments and was approved by the institutional ethics board of Ludwig Maximilians University (LMU) Munich (IRB 22–0353). Competing interests: Author AH reports compensation for scientific consulting by advanced biochemical compounds (ABX).

Figures

Fig. 1
Fig. 1
Example of SUV-thresholding for an extraosseous meningioma located in the right temporal region, prior to any treatment. The images are displayed in four columns, showing different modalities at the same axial level. From left to right: CE-CT, PET scan, fused PET/CT image, and corresponding CE-MRI on the far right
Fig. 2
Fig. 2
PET images showing 3D segmentations of the same extraosseous meningioma presented in Fig. 1, using an individualized threshold of 4.5 (red contour) and a fixed threshold of 4.0 (blue contour). The substantial overlap between segmentations demonstrates a high degree of concordance between the two methods, with only minimal differences in segmented volumes (39.3 ml vs. 37.2 ml)
Fig. 3
Fig. 3
Distribution of Standardized Uptake Values (SUV) across different anatomical locations of meningiomas, including the median SUVmax and SUVmean for both total and intraosseous parts of meningiomas. Osseous segmentation was performed using HU-thresholding (300–3000 HU) within the segmented volume defined by the individualized SUVmin. Each boxplot illustrates the variability and central tendency of SUV values at distinct anatomical sites, highlighting differences in uptake based on the meningioma location. The notches in the boxplots represent the confidence interval around the median, providing a visual indication of the variability in the data. A non-overlapping notch between two boxplots suggests a statistically significant difference in the medians of the two groups
Fig. 4
Fig. 4
(A) Median optimal SUV threshold values (SUVmin) for the delineation of meningioma lesions with different extensions, alongside median SUVmean values for non-meningioma structures in the subarachnoid space and the unaffected bone of the contralateral side. This comparison did not reveal a significant difference in SUVmin between lesions with and without osseous involvement (Mann–Whitney U test, p = 0.1). (B) Overall SUV metrics
Fig. 5
Fig. 5
Scatter plot comparing lesion volumes for each individual lesion segmented using the individualized optimal SUVmin based on morphological comparison (y-axis) with volumes obtained using a fixed SUV cut-off of 4 (x-axis). Each blue dot represents an individual observation. The dashed red line represents equality, indicating identical values for both volume measurements. The intraclass correlation coefficient (ICC[A,1]) was 0.967 (95% CI: 0.952–0.977), indicating excellent agreement between the two methods. However, for very small lesions with volumes < 1 cm³, a divergence between the volumes becomes apparent

References

    1. Claus EB, Bondy ML, Schildkraut JM, Wiemels JL, Wrensch M, Black PM. Epidemiology of intracranial meningioma. Neurosurgery. 2005;57:1088–95. - DOI - PubMed
    1. Ivanidze J, Roytman M, Lin E, Magge RS, Pisapia DJ, Liechty B, et al. Gallium-68 DOTATATE PET in the evaluation of intracranial meningiomas. J Neuroimaging. 2019;29:650–6. - DOI - PubMed
    1. Goldbrunner R, Stavrinou P, Jenkinson MD, Sahm F, Mawrin C, Weber DC, et al. EANO guideline on the diagnosis and management of meningiomas. Neurooncology. 2021;23:1821–34. - PMC - PubMed
    1. Galldiks N, Albert NL, Sommerauer M, Grosu AL, Ganswindt U, Law I, et al. PET imaging in patients with meningioma-report of the RANO/PET group. Neuro Oncol. 2017;19:1576–87. 10.1093/neuonc/nox112. - DOI - PMC - PubMed
    1. Rachinger W, Stoecklein VM, Terpolilli NA, Haug AR, Ertl L, Pöschl J, et al. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med. 2015;56:347–53. 10.2967/jnumed.114.149120. - DOI - PubMed

Publication types

Substances